{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:19:32Z","timestamp":1773868772723,"version":"3.50.1"},"reference-count":11,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,2,1]]},"abstract":"<jats:p>Objective. To characterize the population and survival of neonatal and pediatric patients transported by Wilford Hall Medical Center (WHMC) on extracorporeal membrane oxygenation (ECMO) since 1985.<\/jats:p><jats:p>Study Design. A retrospective chart, literature, and database review of pediatric and neonatal patients transported on ECMO by the WHMC ECMO transport team. In addition, a subpopulation analysis was performed comparing neonates with meconium aspiration syndrome (MAS) placed on ECMO at WHMC with those infants with MAS transported on ECMO. Characteristics of interest for this comparison included disease severity before ECMO, age at initiation of ECMO, survival, ECMO-related complications, and duration of ECMO support.<\/jats:p><jats:p>Results. Forty-two patients transported on ECMO were identified: 23 neonatal respiratory cases (survival 57%), 7 pediatric respiratory cases (survival 71%), 4 cardiac cases (survival 50%), and 8 extra-institutional ECMO transports (survival 63%). In the MAS subpopulation, there was significantly greater survival in the in-house group\u201497% (31\/32)\u2014than in the ECMO transport group\u201475% (9\/12); there were no other significant differences between these groups. Overall, no ECMO-related complications leading to patient demise could be identified in the ECMO transport group.<\/jats:p><jats:p>Conclusions. ECMO transport, although demonstrating acceptable survival, is a risk-laden modality that should not replace early referral to an ECMO center.<\/jats:p>","DOI":"10.1542\/peds.109.2.189","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:17:55Z","timestamp":1092442675000},"page":"189-193","source":"Crossref","is-referenced-by-count":52,"title":["A 16-Year Neonatal\/Pediatric Extracorporeal Membrane Oxygenation Transport Experience"],"prefix":"10.1542","volume":"109","author":[{"suffix":"Jr","given":"Bernard J.","family":"Wilson","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Section of Newborn Medicine, San Antonio Military Pediatric Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard S.","family":"Heiman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Newborn Medicine, San Antonio Military Pediatric Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Butler","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital Medical Center of Akron, Akron, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Negaard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Newborn Medicine, San Antonio Military Pediatric Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"DiGeronimo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Newborn Medicine, San Antonio Military Pediatric Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2002,2,1]]},"reference":[{"key":"2021121006143304400_R1","unstructured":"Extracorporeal Life Support Organization. ELSO Registry Report, International Summary. Ann Arbor, MI: ELSO; July2001"},{"key":"2021121006143304400_R2","unstructured":"Cornish JD, Carter JM, Gerstmann DR, et al. Extracorporeal membrane oxygenation as a means of stabilizing and transporting high risk neonates. ASAIO Trans.1991;37:564\u2013568"},{"key":"2021121006143304400_R3","doi-asserted-by":"crossref","unstructured":"Roy BJ, Rycus P, Conrad SA, et al. The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the ELSO registry. Pediatrics.2000;106:1334\u20131338","DOI":"10.1542\/peds.106.6.1334"},{"key":"2021121006143304400_R4","doi-asserted-by":"crossref","unstructured":"Heulitt MJ, Taylor BJ, Faulkner SC, et al. Interhospital transport of neonatal patients on extracorporeal membrane oxygenation: mobile ECMO. Pediatrics.1995;95:562\u2013566","DOI":"10.1542\/peds.95.4.562"},{"key":"2021121006143304400_R5","doi-asserted-by":"crossref","unstructured":"Boedy RF, Howell CG, Kanto WP. Hidden mortality rate associated with extracorporeal membrane oxygenation. J Pediatr.1990;117:462\u2013464","DOI":"10.1016\/S0022-3476(05)81098-4"},{"key":"2021121006143304400_R6","doi-asserted-by":"crossref","unstructured":"Clark RH, Yoder BA, Sell MS. Prospective, randomized comparison of high frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr.1994;124:447\u2013454","DOI":"10.1016\/S0022-3476(94)70374-4"},{"key":"2021121006143304400_R7","doi-asserted-by":"crossref","unstructured":"Lotze A, Mitchell BR, Bulas DI, et al. Multicenter study of surfactant (beractant) in treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr.1998;132:40\u201347","DOI":"10.1016\/S0022-3476(98)70482-2"},{"key":"2021121006143304400_R8","doi-asserted-by":"crossref","unstructured":"The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med.1997;336:597\u2013604","DOI":"10.1056\/NEJM199702273360901"},{"key":"2021121006143304400_R9","doi-asserted-by":"crossref","unstructured":"Wilson JM, Bower LK, Thompson JE, et al. ECMO in evolution: the impact of changing patient demographics and alternative therapies on ECMO. J Pediatr Surg.1996;31:1116\u20131123","DOI":"10.1016\/S0022-3468(96)90099-8"},{"key":"2021121006143304400_R10","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Fetus and Newborn. Use of inhaled nitric oxide. Pediatrics.2000;106:344\u2013345","DOI":"10.1542\/peds.106.2.344"},{"key":"2021121006143304400_R11","doi-asserted-by":"crossref","unstructured":"Davidson D, Barefield ES, Kattwinkel J, et al. Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn. Pediatrics.1999;104:231\u2013236","DOI":"10.1542\/peds.104.2.231"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/2\/189\/1113411\/pe0202000189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/2\/189\/1113411\/pe0202000189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:39:45Z","timestamp":1682746785000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/109\/2\/189\/63949\/A-16-Year-Neonatal-Pediatric-Extracorporeal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":11,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2002,2,1]]},"published-print":{"date-parts":[[2002,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.109.2.189","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2,1]]}}}